CYTOMX THERAPEUTICS INC. WKN: A14158 ISIN: US23284F1057 Kürzel: CTMX Forum: Aktien Thema: Hauptdiskussion
The offering was led by Longitude Capital and also included participation from OrbiMed, Venrock Healthcare Capital Partners, Vivo Capital, RTW Investments, and a large investment management firm, among other funds. Jefferies and Piper Sandler are acting as joint book-running managers for the offering.
The offering was led by Longitude Capital and also included participation from OrbiMed, Venrock Healthcare Capital Partners, Vivo Capital, RTW Investments, and a large investment management firm, among other funds. Jefferies and Piper Sandler are acting as joint book-running managers for the offering.
|
|
Thema | ||
|---|---|---|---|
| 1 | Aktuelles zu Almonty Industries | +0,35 % | |
| 2 | Viridian Therapeutics | +28,62 % | |
| 3 | Virgin Galactica | ±0,00 % | |
| 4 | bitcoin&gamestop | -0,21 % | |
| 5 | DRONESHIELD LTD Hauptdiskussion | ±0,00 % | |
| 6 | Palantir ohne Schnickschnack | +0,21 % | |
| 7 | Hensoldt | ±0,00 % | |
| 8 | OTL nach dem RS 1:20 | +1,30 % | |
| 9 | ALLIANZ Hauptdiskussion | ±0,00 % | |
| 10 | Strategy B | +1,39 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Aktuelles zu Almonty Industries | +0,35 % | |
| 2 | Viridian Therapeutics | +28,62 % | |
| 3 | Virgin Galactica | ±0,00 % | |
| 4 | bitcoin&gamestop | -0,21 % | |
| 5 | DRONESHIELD LTD Hauptdiskussion | ±0,00 % | |
| 6 | Palantir ohne Schnickschnack | +0,21 % | |
| 7 | Hensoldt | ±0,00 % | |
| 8 | OTL nach dem RS 1:20 | +1,30 % | |
| 9 | ALLIANZ Hauptdiskussion | ±0,00 % | |
| 10 | Strategy B | +1,39 % | Alle Diskussionen |